Pliant Therapeutics, Inc.
PLRX· Nasdaq
Released Aug 9, 2023, after the close
10-Q filed Aug 9, 2023, 40 days after period end · 0001746473-23-000053
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Revenue | $248.00K | $4.99M | $1.79M | $3.60M |
| Net Income | -$41.19M | -$29.55M | -$22.83M | -$17.00M |
| EPS Diluted |
Pliant Therapeutics, Inc. · CIK 1746473 · Engraved from SEC EDGAR
| -$0.70 |
| -$0.82 |
| -$0.64 |
| -$1.39 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.